Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gion

Showing results (81-90 of 121) with videos related to

Pageof 13
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Relationship between cathepsin D and other pathological and biological parameters in 1752 patients with primary breast cancerM Gion, R Mione, R Dittadi, et al.
Angiogenesis|January 1, 1997
Co-determination of the angiogenic factors thymidine phosphorylase and vascular endothelial growth factor in node-negative breast cancer: prognostic implicationsM Toi, M Gion, E Biganzoli, et al.
Breast Cancer Research and Treatment|June 1, 2000
Quantitative measurement of soluble cytokeratin fragments in tissue cytosol of 599 node negative breast cancer patients: a prognostic marker possibly associated with apoptosisM Gion, P Boracchi, R Dittadi, et al.
European Journal of Cancer (Oxford, England : 1990)|April 23, 2003
Blood glutathione as a surrogate marker of cancer tissue glutathione S-transferase activity in non-small cell lung cancer and squamous cell carcinoma of the head and neckE Ferruzzi, R Franceschini, G Cazzolato, et al.
British Journal of Cancer|August 1, 1993
PS2 in breast cancer--alternative or complementary tool to steroid receptor status? Evaluation of 446 casesM Gion, R Mione, G L Pappagallo, et al.
The International Journal of Biological Markers|July 1, 1994
Evaluation of critical differences of CEA and CA 15.3 levels in serial samples from patients operated for breast cancerM Gion, G Cappelli, R Mione, et al.
The International Journal of Biological Markers|October 1, 1994
Clinical profile of a new monoclonal antibody-based immunoassay for tissue polypeptide antigenM Correale, H Arnberg, P Blockx, et al.
Tumori|March 1, 1995
Comparison of immunoassays for tumor markers CA 19-9, CA 15-3 and CA 125: data from an international quality assessment schemeA Pilo, G C Zucchelli, R Cohen, et al.
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|January 1, 1991
Tumor-associated trypsin inhibitor (TATI) in primary esophageal carcinomaM Gion, R Mione, C Tremolada, et al.
The International Journal of Biological Markers|July 1, 1991
TAF test in primary esophageal carcinoma: comparison with other tumor markersW Taccone, M Gion, F Pecchio, et al.
Pageof 13

Showing results (81-90 of 121) with videos related to

Sort By:
Pageof 13
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Relationship between cathepsin D and other pathological and biological parameters in 1752 patients with primary breast cancerM Gion, R Mione, R Dittadi, et al.
Angiogenesis|January 1, 1997
Co-determination of the angiogenic factors thymidine phosphorylase and vascular endothelial growth factor in node-negative breast cancer: prognostic implicationsM Toi, M Gion, E Biganzoli, et al.
Breast Cancer Research and Treatment|June 1, 2000
Quantitative measurement of soluble cytokeratin fragments in tissue cytosol of 599 node negative breast cancer patients: a prognostic marker possibly associated with apoptosisM Gion, P Boracchi, R Dittadi, et al.
European Journal of Cancer (Oxford, England : 1990)|April 23, 2003
Blood glutathione as a surrogate marker of cancer tissue glutathione S-transferase activity in non-small cell lung cancer and squamous cell carcinoma of the head and neckE Ferruzzi, R Franceschini, G Cazzolato, et al.
British Journal of Cancer|August 1, 1993
PS2 in breast cancer--alternative or complementary tool to steroid receptor status? Evaluation of 446 casesM Gion, R Mione, G L Pappagallo, et al.
The International Journal of Biological Markers|July 1, 1994
Evaluation of critical differences of CEA and CA 15.3 levels in serial samples from patients operated for breast cancerM Gion, G Cappelli, R Mione, et al.
The International Journal of Biological Markers|October 1, 1994
Clinical profile of a new monoclonal antibody-based immunoassay for tissue polypeptide antigenM Correale, H Arnberg, P Blockx, et al.
Tumori|March 1, 1995
Comparison of immunoassays for tumor markers CA 19-9, CA 15-3 and CA 125: data from an international quality assessment schemeA Pilo, G C Zucchelli, R Cohen, et al.
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|January 1, 1991
Tumor-associated trypsin inhibitor (TATI) in primary esophageal carcinomaM Gion, R Mione, C Tremolada, et al.
The International Journal of Biological Markers|July 1, 1991
TAF test in primary esophageal carcinoma: comparison with other tumor markersW Taccone, M Gion, F Pecchio, et al.
Pageof 13